According to Arovella Therapeutics latest financial reports the company has an operating margin of -23.85%, an decrease of -7.13% to 2022. At the end of 2022 company had an operating margin of -25.68%.
Year | Operating Margin | Change |
---|---|---|
2023 | -23.85% | -7.13% |
2022 | -25.68% | 41.63% |
2021 | -18.13% | 101.41% |
2020 | -9.00% | - |